Covid-19 Drug Racket: Pharma firm MD and 7 others busted

HYDERABAD: A Pharma firm MD and 7 othersin Hyderabad who were Black-marketing the covid-19 drugs were arrested by the Task Force. A chain of middlemen was used by the gang to supply drugs to patients.

K Venkata Subramanyam alias Phani, the MD of Sri Medicure Products (OPC) Private Limited, revealed that he procured drugs like Remdesivir and FabiFlu from the Hetero Pharma unit in Sangareddy district.

A drug, Tocilizumab, was also procured through Gagan Khurana (21), a Delhi- based supplier. Whatsapp platform was used by the gang and the business was running from past one month. The gang also accepted cash and UPI payment. “Drugs worth Rs 35 were seized from their possession”, according to Hyderabad Police Commissioner Anjani Kumar.
Police further said that, “K Venkata Subramanyam used to sold the drug first to Santosh Kumar. Afterwards, it changed many people till it reached the client. A margin of around Rs 4,000 were kept by each person. Inquiries also revealed that Remdesivir is available at Rs 5,400 per unit, but the gang members used to sale it for around Rs 40,000 and Tocilizumab which costs Rs 40,000 per unit, was being sold for more than Rs 1 lakh.

These drug is used to treat Covid-19 patients who are in the ventilator stage. Several patients who purchased the drug from the gang have been recovered. who Supplier of Tocilizumab to Phani, Gagan Khurana flew away to the city to deliver the medicines when he was arrested. Police officials are further investigating whether the gang supplied drugs in neighboring states as well.

  • Related Posts

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?